Onatasertib
Product Specifications
CAS Number
1228013-30-6
Target
Apoptosis, DNA-PK, FLT, mTOR, c-Fms, PI3K
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, PI3K/Akt/mTOR signaling, Apoptosis, DNA Damage/DNA Repair
Purity
0.9993
Bioactivity
Onatasertib (CC223) is an orally available mTOR inhibitor with potential antitumor activity. Onatasertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. Onatasertib is a potent mTOR kinase inhibitor (IC50: 16 nM), with >150-fold sensitivity than the related lipid kinase PI3Kα (IC50: 4 μM) .
Smiles
CO[C@H]1CC[C@@H](CC1)N1C(=O)CNc2ncc(nc12)-c1ccc(nc1)C(C)(C)O
Molecular Formula
C21H27N5O3
Molecular Weight
397.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130573 100 µg
NRP1 (VEGF165R, Neuropilin-1, Vascular Endothelial Cell Growth Factor 165 Receptor, CD304, DKFZp686A03134, DKFZp781F1414)
Sign In for Pricing
View Details 
141503 200 µL
Mucin 5 Subtype B (MUC5B, MUC5-B, MUC9; MG1, Oligomeric Mucus/Gel-Forming; Mucin 5, Subtype B, Tracheobronchial)
Sign In for Pricing
View Details 246351 200 µL
FRS2 (Fibroblast Growth Factor Receptor Substrate 2, FRS2A, FRS2alpha, SNT, SNT-1, SNT1)
Sign In for Pricing
View Details